COAST Therapy in Advanced Solid Tumors and Prostate Cancer

Recruiting

Phase 1

Phase 2

COAST Therapy in Advanced Solid Tumors and Prostate CancerCOAST Therapy in Advanced Solid Tumors and Prostate Cancer

Sponsor:

Medical University of South Carolina

Code:

NCT05036226

Conditions

Prostate Cancer Recurrent

Solid Tumor, Adult

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Hydroxychloroquine, Metformin, Sirolimus

Hydroxychloroquine, Metformin, Sirolimus, Dasatanib

Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir

Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir, Dasatinib

Hydroxychloroquine, Metformin, Sirolimus, Nelfinavir

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Medical University of South Carolina on 2025-03-25.